Sectors
MBX
MBX Biosciences, Inc. Common Stock
57.91
1 x 57.91
1 x 58.02
bid
ask
-
2.37
3.93%
11:14 AM
timesize
| Ytd | 83.62% | |
| 1y | 394.98% |
57.26
day range
60.65
9.63
52 week range
66.55
| Open | 60.18 | Prev Close | 60.28 | Low | 57.26 | High | 60.65 | Mkt Cap | 2.02B |
| Vol | 124.28K | Avg Vol | 846.54K | EPS | -2.21 | P/E | -27.28 | Forward P/E | -15.54 |
| Beta | 0.16 | Short Ratio | 5.62 | Inst. Own | 120.25% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 43.54 | 200-d Avg | 33.08 | 1yr Est | 69.00 |
| Income Statement | |||
| Operating Expenses | 27.27M | ||
| Research and Development Expense | 18.47M | ||
| Selling, General and Administrative Expense | 8.79M | ||
| Operating Income | -27.26M | ||
| Net Income | -23.52M | ||
| Net Income Common Stock | -23.52M | ||
| Net Income Common Stock (USD) | -23.52M | ||
| Consolidated Income | -23.52M | ||
| Earnings per Basic Share | -0.50 | ||
| Earnings per Basic Share (USD) | -0.50 | ||
| Earnings per Diluted Share | -0.50 | ||
| Earning Before Interest & Taxes (EBIT) | -23.52M | ||
| Earning Before Interest & Taxes (USD) | -23.52M | ||
| Weighted Average Shares | 46.58M | ||
| Weighted Average Shares Diluted | 46.58M | ||
| Balance Sheet | |||
| Cash and Equivalents | 45.21M | ||
| Cash and Equivalents (USD) | 45.21M | ||
| Investments | 394.76M | ||
| Investments Current | 394.76M | ||
| Current Assets | 448.54M | ||
| Property, Plant & Equipment Net | 3.59M | ||
| Total Assets | 452.70M | ||
| Debt Current | 178.00K | ||
| Total Debt | 555.00K | ||
| Current Liabilities | 14.57M | ||
| Debt Non-Current | 377.00K | ||
| Total Liabilities | 14.95M | ||
| Accumulated Retained Earnings (Deficit) | -247.99M | ||
| Accumulated Other Comprehensive Income | -606.00K | ||
| Shareholders Equity | 437.76M | ||
| Shareholders Equity (USD) | 437.76M | ||
| Assets Non-Current | 4.17M | ||
| Total Debt (USD) | 555.00K | ||
| Liabilities Non-Current | 378.00K | ||
| Trade and Non-Trade Payables | 6.97M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 98.00K | ||
| Net Cash Flow from Financing | 87.44M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -29.87M | ||
| Capital Expenditure | -437.00K | ||
| Issuance (Purchase) of Equity Shares | 87.81M | ||
| Net Cash Flow from Investing | -97.10M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -96.66M | ||
| Net Cash Flow from Operations | -20.21M | ||
| Share Based Compensation | 5.48M | ||